Billionaire Masayoshi Son’s SoftBank Claims $5B Stake In Roche: Bloomberg
SoftBank Group Corp (OTC:SFTBF) has quietly acquired a $5 billion stake in Roche Holdings AG (OTC:RHHBF), making it one of the…
EQRx And AbCellera Announce Collaboration To ‘Accelerate the Advancement of New Innovative Medicines’; Financial Terms Not Disclosed
EQRx, a company committed to developing and delivering important new medicines at radically lower prices, and AbCellera (NASDAQ:ABCL), a technology company with a centralized operating system for next-generation antibody
Analyzing AbCellera Biologics’s Unusual Options Activity
Shares of AbCellera Biologics (NASDAQ:ABCL) saw some unusual options activity on Tuesday. Following the unusual option alert, the stock price moved down to $15.49.
Stocks That Hit 52-Week Lows On Friday
Before 10 a.m. ET Friday, 117 stocks made new 52-week lows.
The Daily Biotech Pulse: J&J, Novartis Report Solid Results, Chembio Soars On COVID Test Order, Lumos Signals Clinical Trial Delay
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 20)
Stocks That Hit 52-Week Lows On Tuesday
Before 10 a.m. ET Tuesday, 64 stocks made new 52-week lows.
The Daily Biotech Pulse: Moderna To Join S&P 500 Index, Thumbs Down For FibroGen’s Anemia Drug, Corvus Shelves COVID Study
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 15)
Stocks That Hit 52-Week Lows On Thursday
During the morning session on Thursday, 152 stocks hit new 52-week lows.
The Daily Biotech Pulse: Galapagos Sinks On Data, J&J Recalls Sunscreen Products, FibroGen Awaits AdCom Verdict, 3 IPOs
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs July 14)